Beginning in 2023, CVS said it would start paying governmental agencies that agree to the settlement terms, according to a Nov. 2 news release. The chain said $4.9 billion will go to states and political subdivisions, and about $130 million is slated for tribal cases, to be paid out over 10 years.
“We are pleased to resolve these longstanding claims and putting them behind us is in the best interest of all parties, as well as our customers, colleagues and shareholders,” Thomas Moriarty, CVS Health’s chief policy officer and general counsel, said in a statement.
Both CVS and Walgreens denied wrongdoing.
“We believe this is in the best interest of the company and our stakeholders at this time, and allows our pharmacists, dedicated healthcare professionals who live and work in the communities they serve, to continue playing a critical role in providing education and resources to help combat opioid misuse and abuse,” Walgreens said in a Nov. 2 statement.
Walmart may join the other two companies with its own opioid settlement fund of $3 billion, Bloomberg reported Nov. 1, citing people familiar with the matter.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
